The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis

American Journal of Ophthalmology

Volumn 134, Issue 1, 2002, Pages 41-46

  Silveira, Claudio ^a,b   Belfort Jr , Rubens ^b,g   Muccioli, Cristina ^b   Holland, Gary N ^c   Victora, Cesar G ^d   Horta, Bernardo L ^e   Yu, Fei ^c   Nussenblatt, Robert B ^f  

^a Clinica Silveira   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c JULES STEIN EYE INSTITUTE   (United States)

^d FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^e Federal University   (Brazil)

^f NATIONAL EYE INSTITUTE   (United States)

^g NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BACTRIM F; COTRIMOXAZOLE;

ADOLESCENT; ADULT; ALLERGIC REACTION; ARTICLE; CHORIORETINITIS; CHORIORETINOPATHY; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MUSCLE CRAMP; NAUSEA AND VOMITING; NECROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; RECURRENCE RISK; RECURRENT DISEASE; SCAR; SCHOOL CHILD; STEVENS JOHNSON SYNDROME; TABLET; TOXOPLASMOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTI-INFECTIVE AGENTS; CHILD; CHORIORETINITIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; TOXOPLASMOSIS, OCULAR; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0036297399     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(02)01527-1     Document Type: Article

References (24)

1. Toxoplasmosis
2. An update on current practices in the management of ocular toxoplasmosis
3. In vivo and in vitro effects of trimethoprim and sulfamethoxazole on Toxoplasma infection
4. In vitro activity of cotrimoxazole on the intracellular multiplication of Toxoplasma gondii
5. Trimethoprim-sulfamethoxazole therapy for ocular toxoplasmosis
6. An unusually high prevalence of ocular toxoplasmosis in southern Brazil
7. Behandlung der toxoplasmose-retinochoroiditis mit atovaquon bei immunokompetenten patienten
8. Antibiotics versus control for Toxoplasma retinochoroiditis
9. Trimethoprim-sulfamethoxazole in the United States
10. Low-dose trimethoprim-sulfamethoxazole prophylaxis for toxoplasmic encephalitis in patients with AIDS
11. Central nervous system toxoplasmosis in AIDS patients: Efficacy of an intermittent maintenance therapy
12. Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome
13. Ocular toxoplasmosis in human immunodeficiency virus-infected patients
14. Ocular toxoplasmosis in AIDS patients
15. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group
16. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: The Chicago Collaborative Treatment Trial
17. Eye manifestations of congenital toxoplasmosis
18. Factors related to the initiation and recurrence of uveitis. XL Edward Jackson Memorial Lecture
19. Toxoplasmic retinochoroiditis: Electron-microscopic and immunofluorescence studies of formalin-fixed tissue
20. Intraocular inflammatory reactions without focal necrotizing retinochoroiditis in patients with acquired systemic toxoplasmosis
21. Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection
22. A follow-up study of Toxoplasma gondii infection in southern Brazil
23. Comparative effect of trimethoprim and pyrimethamine, alone and in combination with a sulfonamide, on Toxoplasma gondii: In vitro and in vivo studies
24. The effect of trimethoprim and sulfamethoxazole on Toxoplasma gondii in vitro and in vivo